Moderna, Inc.
Explore Moderna, Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Moderna, Inc.
Explore Moderna, Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2024 Revenue
$3.2B
▼ 52.4% vs FY2023 ($6.8B)
Source: Annual report / company filing
Moderna, Inc. reported $3.2B in revenue for fiscal year 2024. This represents a decline of 52.4% compared to the 2023 figure of $6.8B. In 2025, revenue declined to $1.9B.
Revenue fell another 52.4% in 2024 to 3.236 billion dollars, reflecting the continued collapse of COVID vaccine demand as governments exited bulk pandemic contracts.
| Year | Revenue | YoY Change |
|---|---|---|
| FY2025 | $1.9B | -39.9% |
| FY2024 | $3.2B | -52.4% |
| FY2023 | $6.8B | -63.0% |
| FY2022 | $18.4B | +4.0% |
| FY2021 | $17.7B | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.